Citation Impact
Citing Papers
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
2009 StandoutNobel
Case Report of a Serious Adverse Event Following the Administration of T Cells Transduced With a Chimeric Antigen Receptor Recognizing ERBB2
2010 Standout
Systemic Targeting of CpG-ODN to the Tumor Microenvironment with Anti–neu-CpG Hybrid Molecule and T Regulatory Cell Depletion Induces Memory Responses in BALB-neuT Tolerant Mice
2008 StandoutNobel
An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
2009
Control of Regulatory T Cells by Co-signal Molecules
2019 StandoutNobel
PR1 vaccination in myeloid malignancies
2008
The −9247 T/C polymorphism in the SOST upstream regulatory region that potentially affects C/EBPα and FOXA1 binding is associated with osteoporosis
2009
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG)
2011
Gene Modification Strategies to Induce Tumor Immunity
2005
Immunosuppressive networks in the tumour environment and their therapeutic relevance
2005 Standout
Costimulatory pathways in transplantation: challenges and new developments
2009
mRNA vaccines — a new era in vaccinology
2018 StandoutNobel
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
Ido expression by dendritic cells: tolerance and tryptophan catabolism
2004 Standout
Interaction of human papillomaviruses with the host immune system: A well evolved relationship
2008
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
2010
Evaluation of HBs, HBc, and frCP Virus-Like Particles for Expression of Human Papillomavirus 16 E7 Oncoprotein Epitopes
2002
From Monocytes to M1/M2 Macrophages: Phenotypical vs. Functional Differentiation
2014 Standout
Immune evasion in human papillomavirus-associated cervical cancer
2002
Cotransfection of dendritic cells with RNA coding for HER-2/neu and 4-1BBL increases the induction of tumor antigen specific cytotoxic T lymphocytes
2005
Active immunization against cancer with dendritic cells: The near future
2001 StandoutNobel
Chimeric virus-like particles for the delivery of an inserted conserved influenza A-specific CTL epitope
2008
Wnt signaling in cancer
2016 Standout
Pattern of Recruitment of Immunoregulatory Antigen-Presenting Cells in Malignant Melanoma
2003
Virus-like particles from rabbit hemorrhagic disease virus can induce an anti-tumor response
2008
Roles of osteoclasts in the control of medullary hematopoietic niches
2014
Cancer immunotherapy: breaking the barriers to harvest the crop
2004 StandoutNobel
Coordinated regulation of myeloid cells by tumours
2012 Standout
Cancer immunotherapy via dendritic cells
2012 Standout
Lrp4, a Novel Receptor for Dickkopf 1 and Sclerostin, Is Expressed by Osteoblasts and Regulates Bone Growth and Turnover In Vivo
2009
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
2007
Recombinant canine parvovirus-like particles express foreign epitopes in silkworm pupae
2011
Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study
2020 Standout
Clinical Impact of Human Coronaviruses 229E and OC43 Infection in Diverse Adult Populations
2013
WNT signaling in bone homeostasis and disease: from human mutations to treatments
2013 Standout
New sequence variants associated with bone mineral density
2008
HIV-Gag VLPs presenting trimeric HIV-1 gp140 spikes constitutively expressed in stable double transfected insect cell line
2011
Wnt/β-Catenin Signaling and Disease
2012 Standout
High-Voltage Electrical Pulses in Oncology: Irreversible Electroporation, Electrochemotherapy, Gene Electrotransfer, Electrofusion, and Electroimmunotherapy
2020 Standout
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Osteoporosis, inflammation and ageing
2005
Sclerostin: how human mutations have helped reveal a new target for the treatment of osteoporosis
2013 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Tolerogenic dendritic cells generated by RelB silencing using shRNA prevent acute rejection
2012
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Paradoxical roles of the immune system during cancer development
2006 Standout
Dendritic cells efficiently cross-prime HLA class I-restricted cytolytic T lymphocytes when pulsed with both apoptotic and necrotic cells but not with soluble cell-derived lysates
2000
The STATs of cancer — new molecular targets come of age
2004 Standout
Regulatory T cells in tumor immunity
2010 StandoutNobel
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
Genetics of osteoporosis: accelerating pace in gene identification and validation
2009
Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation
2013 StandoutNature
CD25<sup>+</sup>CD4<sup>+</sup> Regulatory T-Cells in Cancer
2005
Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty
2018 Standout
Update on Wnt signaling in bone cell biology and bone disease
2011
Wnt/β-Catenin Signaling, Disease, and Emerging Therapeutic Modalities
2017 Standout
The Immunobiology of Cancer Immunosurveillance and Immunoediting
2004 Standout
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
NF-κB: linking inflammation and immunity to cancer development and progression
2005 Standout
Manipulating dendritic cell biology for the active immunotherapy of cancer
2004
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
2006 StandoutScience
Peptide Antimicrobial Agents
2006 Standout
Vaccination, immune and gene therapy based on virus-like particles against viral infections and cancer
2007
Stimulation of the Glucocorticoid-Induced TNF Receptor Family-Related Receptor on CD8 T Cells Induces Protective and High-Avidity T Cell Responses to Tumor-Specific Antigens
2010 StandoutNobel
A Simple Detection Method for Low-Affinity Membrane Protein Interactions by Baculoviral Display
2008 StandoutNobel
Dendritic Cells Initiate Immune Control of Epstein-Barr Virus Transformation of B Lymphocytes In Vitro
2003 StandoutNobel
Nonviral Vectors for Gene Delivery
2008 Standout
Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion
2011 StandoutScience
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
A subset of dendritic cells induces CD4+ T cells to produce IFN-γ by an IL-12–independent but CD70-dependent mechanism in vivo
2007 StandoutNobel
Self-Reactive T Cells Selected on Thymic Cortical Epithelium Are Polyclonal and Are Pathogenic In Vivo
1999
Human Papillomavirus and Cervical Cancer
2003 Standout
Cross-presentation of tumor antigens by bone marrow–derived antigen-presenting cells is the dominant mechanism in the induction of T-cell tolerance during B-cell lymphoma progression
2001
Avoiding horror autotoxicus: The importance of dendritic cells in peripheral T cell tolerance
2002 StandoutNobel
PAPILLOMAVIRUS BINDING AND ENTRY The heparan sulfate receptor and inhibition by lactoferrin
2005
Does the Immune System See Tumors as Foreign or Self?
2003
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Modulation of cord blood CD8+ T-cell effector differentiation by TGF-β1 and 4-1BB costimulation
2004
TRANSFORMING GROWTH FACTOR-β REGULATION OF IMMUNE RESPONSES
2005 Standout
CD4+ T Cell-Mediated Antigen-Specific Immunotherapy in a Mouse Model of Cervical Cancer
2005
CD8 T Cell-Intrinsic GITR Is Required for T Cell Clonal Expansion and Mouse Survival following Severe Influenza Infection
2010 StandoutNobel
Tolerogenic Dendritic Cells
2003 StandoutNobel
Immunological Response to Parenteral Vaccination with Recombinant Hepatitis B Virus Surface Antigen Virus-Like Particles Expressing Helicobacter pylori KatA Epitopes in a Murine H. pylori Challenge Model
2011
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
TNF/TNFR FAMILY MEMBERS IN COSTIMULATION OF T CELL RESPONSES
2004
T Cell Activation
2009 Standout
Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
2019
Works of Tracy Doan being referenced
Differences in the effectiveness of delivery of B- and CTL-epitopes incorporated into the Hepatitis B core antigen (HBcAg) c/e1-region
1999
A polytope DNA vaccine elicits multiple effector and memory CTL responses and protects against human papillomavirus 16 E7-expressing tumour
2004
Mice Expressing the E7 Oncogene of HPV16 in Epithelium Show Central Tolerance, and Evidence of Peripheral Anergising Tolerance, to E7-Encoded Cytotoxic T-Lymphocyte Epitopes
1998
Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen
2003
Hepatitis B Surface Antigen Vector Delivers Protective Cytotoxic T-Lymphocyte Responses to Disease-Relevant Foreign Epitopes
2006
Human Papillomavirus Type 16 E7 Oncoprotein Expressed in Peripheral Epithelium Tolerizes E7-Directed Cytotoxic T-Lymphocyte Precursors Restricted through Human (and Mouse) Major Histocompatibility Complex Class I Alleles
1999
Peripheral tolerance to human papillomavirus E7 oncoprotein occurs by cross-tolerization, is largely Th-2-independent, and is broken by dendritic cell immunization.
2000
Enhanced Effector and Memory CTL Responses Generated by Incorporation of Receptor Activator of NF-κB (RANK)/RANK Ligand Costimulatory Molecules into Dendritic Cell Immunogens Expressing a Human Tumor-Specific Antigen
2003
Genetic Analyses in a Sample of Individuals With High or Low BMD Shows Association With Multiple Wnt Pathway Genes
2007
Nonspecific Down-Regulation of CD8+T-Cell Responses in Mice Expressing Human Papillomavirus Type 16 E7 Oncoprotein from the Keratin-14 Promoter
2001